Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer
Condition: Breast Cancer Interventions: Drug: EG12014; Drug: Herceptin Sponsor: EirGenix, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials